Intermittent fasting encompasses several protocols: time-restricted eating (TRE, typically 16:8), alternate-day fasting, and the 5:2 method. Dr. Satchin Panda (Salk Institute), who popularized TRE through his circadian biology research, estimates that 10% of American adults practice some form of IF. The largest and most rigorous trials have been published in the past three years, and the results are more nuanced than either camp admits.
The TREAT trial (2020, JAMA Internal Medicine, n=116, led by Dr. Ethan Weiss at UCSF) made headlines when it found TRE produced weight loss, but DEXA scans revealed approximately 65% of the weight lost was lean mass, not fat. This finding was concerning — though critics including Dr. Krista Varady (University of Illinois Chicago), the leading IF researcher with over 80 published papers on the topic, noted that the study did not control protein intake or include resistance training, both of which are standard co-interventions in fat-loss protocols.
Metabolic benefits beyond weight loss have been more consistently demonstrated. A 2022 Nutrients meta-analysis (k=19, n=972, led by Dr. Michelle Harvie at the University of Manchester) found that TRE protocols reduced fasting insulin by 11%, improved HOMA-IR by 19%, and lowered hs-CRP by 14% compared to ad libitum eating, even when total caloric intake was matched. The metabolic improvements appear at least partly independent of weight loss.
Timing matters substantially. Dr. Courtney Peterson (University of Alabama at Birmingham) published a crossover RCT (2019, Cell Metabolism, n=11) showing that early TRE (eating window 8 a.m. to 2 p.m.) improved insulin sensitivity, blood pressure, and oxidative stress markers compared to a control schedule — with no weight loss at all. This aligns with circadian biology: insulin sensitivity peaks in the morning and declines through the day, as demonstrated in Dr. Panda's foundational mouse studies (Cell Metabolism, 2012).
A 2024 AHA abstract (n=20,078, NHANES data, presented at the Epidemiology and Prevention conference) found that adults who ate within an 8-hour window had a 91% higher risk of cardiovascular death compared to those eating over 12-16 hours. However, this was an observational study with significant confounders (sicker people may naturally eat less), and it contradicts the intervention trial data. The AHA stressed the finding was preliminary and should not change clinical practice.
Who should avoid intermittent fasting: individuals with a history of eating disorders (Dr. Cynthia Bulik at UNC has documented that rigid eating windows can trigger restriction patterns), pregnant or lactating women, individuals with type 1 diabetes or on insulin or sulfonylurea therapy, and anyone on medications requiring food intake at specific times.